Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teladoc Health Inc (TDOC) vs Vale SA (VALE) Price & Performance

Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Teladoc Health Inc vs Vale SA — how do they compare? Teladoc Health Inc trades at $5.54 (market cap $1.01B), while Vale SA trades at $13.5 (market cap $58.70B). The key difference: Vale SA is far larger — about 58.1× Teladoc Health Inc's market cap, and Vale SA pays a 8.75% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Vale SA for 109 Days on average.

TDOCVALE
Market Cap
$1.01B$58.70B
Volume
3,622,44045,073,516
Sector
HealthBasic Materials
52-Week High
$9.72$17.82
52-Week Low
$4.47$10.75
Typical Hold Time
39 Days109 Days
Enterprise Value
$1.27B$74.94B
Dividend Yield
—8.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.54, down 3.99% in the latest session, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with oversold conditions while fundamentals reveal a mixed picture - strong gross margins of 68.97% but persistent net losses. Recent management changes and legal investigations add uncertainty, though the company maintains solid cash flow from operations of $294.36 million.

TDOC presents a high-risk opportunity with significant upside potential given the $8.83 consensus price target, representing 59% upside. However, continued net losses, negative cash flow trends, and competitive pressures in telehealth create substantial execution risk. The stock's current valuation at 0.4x sales appears attractive if the company can achieve profitability.

Vale SA

VALE trades at $13.42, down 4.69% today amid broader sector weakness. The stock shows bearish technical signals with recent earnings misses and declining profit margins (5.11% net margin in 2025). Revenue has stabilized around $38-41B, but net income fell to $2.35B in 2025 from $18.8B in 2022. The company maintains strong cash flow generation ($8.8B operating cash flow) and recently declared a $0.40 dividend payable September 2026.

VALE faces headwinds from iron ore price volatility and rising costs, but base metals growth provides diversification. Analyst consensus is mixed with 32% buy ratings and a $16.21 price target suggesting 21% upside. Key risks include Brazilian regulatory exposure and cyclical commodity dependence. The current valuation (P/E 27.22) appears stretched given earnings compression.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TDOC

No sentiment data available yet.

VALE
96% Buy4% Sell
Avg holding period · 109 Days

Top news

Latest headlines on both assets

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →

About Vale SA

Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.

Read more on VALE →